Testing drugs in pediatric populations: the FDA mandate.
D000293:Adolescent; D002648:Child; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D033242:Minors; D033281:Nontherapeutic Human Experimentation; D010372:Pediatrics; D004364:Pharmaceutical Preparations; D010919:Placebos; D011897:Random Allocation; D012106:Research; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012952:Societies; D036302:Therapeutic Human Experimentation; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration
American Academy of Pediatrics; Biomedical and Behavioral Research; Legal Approach